ArticleChemistry & biodiversity2026
Discovery of Virulence Attenuator of Chromobacterium violaceum CV026 From Marine-Derived Fungus Aspergillus ochraceus LSD-13 by Inhibiting Quorum Sensing and Destroying Biofilm.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Targeted quorum-sensing (QS) represents a promising approach to combat multidrug-resistant infections. In this study, an undescribed pyrazine derivative 5-isobutyryl-1,4-dihydropyrazine-2,3-dione (1) together with three known compounds (2--4) were isolated from the marine-derived fungus Aspergillus ochraceus LSD-13. Compound 2 was a potent virulence attenuator of Chromobacterium violaceum CV026 with a minimum inhibitory concentration (MIC) of 32 µg/mL. At sub-MIC, compound 2 significantly suppressed the production of QS-controlled phenotypes: violacein, N-acyl homoserine lactone, chitinase, and extracellular polysaccharide. It also reduced biofilm formation by 73.3% at 1/2 MIC, a phenotype confirmed by scanning electron microscopy. Furthermore, compound 2 inhibited swarming motility in a dose-dependent manner. Mechanistic investigations revealed that compound 2 downregulated the expression of QS-associated genes (cviR, vioA, vioC). Molecular docking demonstrated that compound 2 has a strong binding affinity for CviR protein with -6.8 kcal/mol, suggesting a competitive antagonism of the native C
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.